Lucas, Peter C.
Guy's Hospital · Institute of Cancer Research · Tel Aviv University · University of Pittsburgh · King's College London · University of Milan · Sheba Medical Center · Breast Cancer Now · UPMC Hillman Cancer Center · University of Pittsburgh Medical Center · NRG Oncology · University of Pennsylvania
4 papers on CoChatORCID 0000-0003-4880-7172
Most cited papers
- Verified
Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer
Tutt, A. N. J., Garber, J. E., Kaufman, B., Viale, G., Fumagalli, D., Rastogi, P., Gelber, R. D., de Azambuja, E., Fielding, A., Balmaña, J., et al. (2021) · New England Journal of Medicine
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 1,729
- Verified
Genetic p53 Deficiency Partially Rescues the Adrenocortical Dysplasia Phenotype at the Expense of Increased Tumorigenesis
Else, T., Trovato, A., Kim, A. C., Wu, Y., Ferguson, D. O., Kuick, R. D., Lucas, P. C., & Hammer, G. D. (2009) · Cancer Cell
Telomeres, Telomerase, and SenescenceCancer-related Molecular Pathways
Cited by 62
- Verified
Neratinib-Plus-Cetuximab in Quadruple-WT ( KRAS, NRAS, BRAF, PIK3CA ) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study
Jacobs, S. A., Lee, J. J., George, T. J., Wade, J. L., Stella, P. J., Wang, D., Sama, A. R., Piette, F., Pogue-Geile, K. L., Kim, R. S., et al. (2021) · Clinical Cancer Research
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 27
- Verified
The API2–MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling
Rosebeck, S., Rehman, A. O., Apel, I. J., Kohrt, D., Appert, A., O'Donnell, M. A., Ting, A. T., Du, M.-Q., Baens, M., Lucas, P. C., et al. (2014) · Oncogene
NF-κB Signaling PathwaysLymphoma Diagnosis and Treatment
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free